Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 1527 of 2922 -
Wednesday, February 25 2026 | 04:43:03 AM

Seabridge Gold Files First Quarter Financial Statements and MD&A

Toronto, Ontario–(Newsfile Corp. – May 13, 2025) – Seabridge Gold (TSX: SEA) (NYSE: SA) announced today that it has filed its Interim Financial Statements and Management’s Discussion and Analysis for the three-month period ended March 31, 2025 on SEDAR+ (https://www.sedarplus.ca). These statements are also available on Seabridge’s website at https://www.seabridgegold.com/investors/financial-reports. …

Read More »

Best Vacation Home Offers Complimentary Consultations to Buyers Seeking Unique International Properties

Vienna, Austria–(Newsfile Corp. – May 13, 2025) – Best Vacation Home, a trusted advisor in the vacation real estate market, today announced it is offering complimentary consultations to individuals and families seeking unique vacation and investment properties. With knowledge in international markets and a commitment to personalized service, Best Vacation …

Read More »

Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher’s Disease

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – May 13, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (“Sharp” or the “Company”), a pre-clinical-stage biotechnology company developing small molecule therapies to treat genetic diseases, announces that it has nominated a small molecule compound from its GBA program for clinical development in Gaucher’s …

Read More »

EMX Royalty Executes an Agreement with Galileo Resources to Acquire a Royalty over the Ferber Polymetallic Project, Nevada, USA

Vancouver, British Columbia–(Newsfile Corp. – May 13, 2025) – EMX Royalty Corporation (NYSE American: EMX) (TSXV: EMX) (the “Company” or “EMX”) is pleased to announce the execution by its wholly-owned subsidiary Bronco Creek Exploration Inc., of an exploration royalty agreement (the “Agreement”) with St. Vincent Minerals US, Inc., a wholly-owned subsidiary …

Read More »

Neural Therapeutics Announces RSU and Options Grant

Toronto, Ontario–(Newsfile Corp. – May 13, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) (“Neural” or the “Company”), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, announces that the Board of Directors approved the grant of 2,720,000 restricted share …

Read More »